Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Mohamed Abdelfatah, MD, Ankit Anand, MD, Zeyad Kanaan, MD, Ali Al-Ameri, MD, Nairmeen Haller, PhD

Blood (2013) 122 (21): 4998.

https://doi.org/10.1182/blood.V122.21.4998.4998

Published: 2013

Journal Articles

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Ahmed Malkawi, MD, Ankit Anand, MD, Ali Al-Ameri, MD, Mohamed Abdelfatah, MD, Zeyad Kanaan, MD, Nairmeen Haller, PhD

Blood (2013) 122 (21): 5007.

https://doi.org/10.1182/blood.V122.21.5007.5007

Published: 2013

Journal Articles

Outcome Of Patients With Acute Myeloid Leukemia/High Risk Myelodysplastic Syndrome Based On Bone Mineral Density: Data From a Single center 2000-2012

Ankit Anand, MD, Hussam Al-sharif, MD, Mohamed Abdelfatah, MD, Nairmeen Haller, PhD, Ali Al-Ameri, MD

Blood (2013) 122 (21): 5008.

https://doi.org/10.1182/blood.V122.21.5008.5008

Published: 2013

Journal Articles

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Ali Al-Ameri, MD, Mohamed Abdelfatah, MD, Zeyad Kanaan, MD, Nairmeen Haller, PhD

Blood (2012) 120 (21): 4796.

https://doi.org/10.1182/blood.V120.21.4796.4796

Published: 2012

Journal Articles

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Ali Al-Ameri Al-Ameri, MD, Hagop Kantarjian, MD, Asifa Malik, MD, Xavier Badoux, MD, Michael Andreeff, MD, PhD, Alfonso Quintas-Cardama, MD, Gautam Borthakur, MD

Blood (2010) 116 (21): 5061.

https://doi.org/10.1182/blood.V116.21.5061.5061

Published: 2010

Journal Articles

Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Ali Al-Ameri, Hagop Kantarjian, Gautam Borthakur, Erkut Bahceci, Ted Szatrowski, Andrew Damokosh, Jorge Cortes

Blood (2009) 114 (22): 1120.

https://doi.org/10.1182/blood.V114.22.1120.1120

Published: 2009

NARROW

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Outcome Of Patients With Acute Myeloid Leukemia/High Risk Myelodysplastic Syndrome Based On Bone Mineral Density: Data From a Single center 2000-2012

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Email alerts

ASH Publications

American Society of Hematology

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Outcome Of Patients With Acute Myeloid Leukemia/High Risk Myelodysplastic Syndrome Based On Bone Mineral Density: Data From a Single center 2000-2012

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only